Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Carrots and Stick: Biopharma At The White House

Executive Summary

Drug industry executives discuss drug pricing and tax and regulatory reform in a high-profile meeting with President Trump at the White House.

Advertisement

Related Content

Biotech Execs Speak Out Against Trump’s Immigration Ban; Big Pharma Remains Mostly Silent
Biotech Execs Speak Out Against Trump’s Immigration Ban; Big Pharma Remains Mostly Silent
Stockwatch: Pfizer, Roche, AZ, Novo Prolong Pharmaceutical Winter
CEOs Tell Trump Tax Cuts Could Bring More Biopharma Plants To US
Trump’s Drug Pricing Remarks: A Gambit For Industry Self-Restraint?
Pharma Is Ready And Waiting For A Tax Holiday Under Trump

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register